Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan

British Journal of Cancer

Volumn 80, Issue 11, 1999, Pages 1838-1843

  Huang, C S ^a   Shen, C Y ^b   Chang, K J ^a   Hsu, S M ^a   Chern, H D ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Breast cancer; CYP1A1; Genetic polymorphism; Susceptibility

Indexed keywords

CARCINOGEN; CYTOCHROME P450 ISOENZYME; ENVIRONMENTAL CHEMICAL; ESTROGEN; ISOLEUCINE; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; ESTROGEN METABOLISM; FAMILY HISTORY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; NERVE FIBER; NULLIPARA; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; SMOKING; TAIWAN;

AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; BREAST NEOPLASMS; CHINA; CONTRACEPTIVES, ORAL; CYTOCHROME P-450 CYP1A1; ESTROGEN REPLACEMENT THERAPY; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; INCIDENCE; ISOLEUCINE; MENARCHE; MIDDLE AGED; PARITY; POLYMORPHISM, GENETIC; PREGNANCY; RISK FACTORS; SMOKING; TAIWAN; VALINE; VARIATION (GENETICS);

EID: 0013568180     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690608     Document Type: Article

References (32)

1. Alexandrie AK, Sundberg MI, Seidegard J, Torniling G and Rannug A (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15: 1785-1790
2. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Laughlin R, Nemoto T, Michalck AM, Harrington A, Ford TD and Shield PG (1995) Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphism and postmenopausal breast cancer risk. Cancer Res 55: 3483-3485
3. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD and Parl FF (1998) Breast cancer and CYP1A1, GSTM1 and GSTT1 polymorphism: evidence of a lack of association in Caucasians and African Americans. Cancer Res 58: 65-70
4. Ball SE, Forrester LM, Wolf CR and Back DJ (1990) Differences in the cytochrome P450 isoenzymes involved in the 2-hydroxylation of estradiol and 17α-ethmylestradiol. Biochem J 267: 221-226
5. Bernstein L, Yuan JM, Ross RK, Pike MC, Hanisch R, Lobo R, Stanczyk F, Gao YT and Henderson BE (1990) Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control 1: 51-58
6. Chie WC, Lee WC, Li CY, Huang CS, Chang KJ, Yen ML and Lin RS (1997) Lactation, lactation suppression hormones and breast cancer: a hospital-based case-control study for parous women in Taiwan. Oncol Rep 4: 319-326
7. Chie WC, Li CY, Huang CS, Chang KJ and Lin RS (1998) Body size factors of different ages and breast cancer risk in Taiwan. Anticancer Res 18: 565-570
8. Drakoutis N, Cascorbi I, Brockmoller J, Gross CR and Roots I (1994) Polymorphism in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clin Invest 72: 240-248.
9. Fishman J, Schneider J, Hershcope RJ and Bradlow HL (1984) Increased estrogen-16α hydroxylase activity in women with breast and endometrial cancer. J Steroid Biochem 20: 1077-1081
10. Hayashi SI, Watanabe J, Nakachi K and Kawajiri K (1991) Genetic linkage of lung cancer-associated Msp1 polymorphism with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 110: 407-411
11. Hirvonen A, Husgafvel-Pursiamen K, Karjalainen A, Anttila S and Vainio H (1992) Point-mutational Msp1 and Ile-Val polymorphism closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomakers Prev 1: 485-489
12. Hunter DJ and Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15: 110-132
13. Ishibe N, Hankinson Sc, Colditz GA, Spiegelman D, Willett WC, Spelzer FE, Kelsey KT and Hunter DJ (1998) Cigarette smoking, cytochrome P4501A1 polymorphism, and breast cancer risk in the nurses health study. Cancer Res 58: 667-671
14. Kato S, Bowman ED, Harrington AM, Blomeke B and Shields PG (1995) Human lung carcinogen-DNA adduct levels mediated by genetic polymorphism in vivo. J Natl Cancer Inst 87: 902-907
15. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N and Watanabe J (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphism of the cytochrome P4501A1 gene. FEBS Lett 263: 131-133
16. Kawajiri K, Nakachi K, Imai K, Watanahe J and Hayashi S (1993) The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14: 77-87
17. Kelsey JL (1993) Breast cancer epidemiology: summary and future directions, Epidemiol Rev 15: 36-47
18. Kihara M and Noda K (1995) Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphism in a Japanese population. Carcinogenesis 16: 2331-2336
19. Klembaum DG, Kupper LL and Morgenstern H (1985) Epidemiologic Research. Van Nostrand Reinhold: New York
20. Li D, Wang M, Dhingra K and Hittelman WN (1996) Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 56: 287-293
21. Lo YL, Yu JC, Huang CS, Tseng SL, Chang TM, Chang KJ, Wu CW and Shen CY (1998) Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). In J Cancer 79: 580-587
22. Nakachi K, Imai K, Hayashi S, Watanabe J and Kawajiri K (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51: 5177-5180
23. Osborne MP, Bradlow HL, Wong GY and Telang NT (1993) Upregulation of estradiol CI6α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 85: 1917-1920
24. Oyama T, Mitsudomi T, Kawamoto T, Ogami A, Osaki T, Kodama Y and Yasumoto K (1995) Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health 67: 253-256
25. Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R and Phillips DH (1995) Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4: 233-238
26. Taioli E, Trachman J, Chen X, Toniolo P and Garte SJ (1995) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55: 3757-3758
27. Yager JD (1996) Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36: 203-232
28. Yang PS, Yang TL, Lui CL, Wu CW and Shen CY (1997) A case-control study of breast cancer in Taiwan: a low incidence area. Br J Cancer 75: 752-756
29. Xu X, Kelsey KT, Wiencke JK, Wain JC and Christiani DC (1996) Cytochrome P450 CYP1A1 Msp1 polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 5: 687-692
30. Zhang ZY, Fasco MJ, Huang L, Guengerich FP and Kaminsky LS (1996) Characterization of purified human recombinant cytochrome P4501A1-Ile and -Val462: Assessment of a role for the rare allele in carcinogenesis. Cancer Res 56: 3926-3933
31. Zhu BT and Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19: 1-27
32. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF and Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85: 1819-1827